Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Sue Hurlburt
January 29, 2019
Steph Smith
January 29, 2019
Serena Wells
January 29, 2019
Roberta Bentley
January 29, 2019
Peter K
January 29, 2019
Peter Allen
January 29, 2019
Pat Peterson
January 29, 2019
Mike Firth – Diver
January 29, 2019
Mick
January 29, 2019
Mary Jo
January 29, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video